Cellectar Biosciences, Inc. Stock Agreements
17 Contracts & Agreements
- Form of Series D Preferred Stock Certificate (Filed With SEC on December 28, 2020)
- Stock Option Agreement with Igor Grachev (Filed With SEC on March 9, 2020)
- Stock Option Agreement with Dov Elefant (Filed With SEC on March 9, 2020)
- Form of Non-Statutory Stock Option (Definitive/Contingent Directors) (Filed With SEC on November 13, 2018)
- Form of Non-Statutory Stock Option (Definitive/Contingent Employees) (Filed With SEC on November 13, 2018)
- Form of Series C Preferred Stock Certificate (Filed With SEC on July 18, 2018)
- Form of Series B Preferred Stock certificate (Filed With SEC on October 11, 2017)
- Cellectar Biosciences, Inc. AMENDED AND RESTATED 2015 STOCK INCENTIVEPLAN (Filed With SEC on June 1, 2017)
- SERIES B PREFUNDED COMMON STOCK PURCHASEWARRANT cellectarbiosciences, inc. (Filed With SEC on September 30, 2015)
- AMENDMENT TO CLASS B COMMON STOCK PURCHASEWARRANT NOVELOS THERAPEUTICS, INC. (Filed With SEC on September 12, 2012)
- CERTIFICATE OF ELIMINATION OF SERIES E CONVERTIBLE PREFERRED STOCK OF NOVELOS THERAPEUTICS, INC. (Pursuant to Section 151(g) of the General Corporation Law of the State of... (Filed With SEC on April 11, 2011)
- CERTIFICATE OF ELIMINATION OF SERIES C 8% CUMULATIVE CONVERTIBLE PREFERRED STOCK OF NOVELOS THERAPEUTICS, INC. (Pursuant to Section 151(g) of the General Corporation Law of the... (Filed With SEC on April 11, 2011)
- AMENDEDMENTTO CONSENT AND WAIVER OFHOLDERS OF SERIES C CONVERTIBLE PREFERRED STOCK AND SERIESE CONVERTIBLE PREFERRED STOCK OFNOVELOS THERAPEUTICS, INC. JULY21, 2010 (Filed With SEC on July 22, 2010)
- WRITTENCONSENT AND WAIVER OFHOLDERS OF SERIES C CONVERTIBLE PREFERRED STOCK AND SERIESE CONVERTIBLE PREFERRED STOCK OFNOVELOS THERAPEUTICS, INC. (Filed With SEC on July 7, 2010)
- CERTIFICATEOF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES ECONVERTIBLE PREFERRED STOCK OF NOVELOSTHERAPEUTICS, INC. (Pursuantto Section 151 of the DelawareGeneral Corporation... (Filed With SEC on February 18, 2009)
- CERTIFICATE OF ELIMINATION OF SERIES A 8% CUMULATIVE CONVERTIBLE PREFERRED STOCK OF NOVELOS THERAPEUTICS, INC. (Pursuant to Section 151(g) of the General Corporation Law of the... (Filed With SEC on April 14, 2008)
- CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES D CONVERTIBLE PREFERRED STOCK OF NOVELOS THERAPEUTICS, INC. (Pursuant to Section 151 of the Delaware General... (Filed With SEC on April 14, 2008)
